Medicover AB (publ) (LON:0RPS)
London · Delayed Price · Currency is GBP · Price in SEK | Market Cap | 2.71B -16.0% |
| Revenue (ttm) | 2.13B +9.3% |
| Net Income | 73.11M +95.6% |
| EPS | 0.48 +94.4% |
| Shares Out | n/a |
| PE Ratio | 37.04 |
| Forward PE | 24.86 |
| Dividend | 0.17 (0.94%) |
| Ex-Dividend Date | Apr 30, 2026 |
| Volume | 12,936 |
| Open | 231.50 |
| Previous Close | 236.00 |
| Day's Range | 231.50 - 234.75 |
| 52-Week Range | 179.60 - 270.50 |
| Beta | 1.50 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 4, 2026 |
About Medicover AB
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company operates through two segments: Healthcare Services and Diagnostic Services. Its Healthcare Services include outpatient and inpatient care; dental care, mental health care, orthopedics, preventive plans and sports, and wellness; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness; hospital care; and preventive care services. The company’s Diagnostic Serv... [Read more]
Financial Performance
In 2025, Medicover AB's revenue was 2.38 billion, an increase of 13.69% compared to the previous year's 2.09 billion. Earnings were 77.50 million, an increase of 364.07%.
Financial numbers in EUR Financial StatementsNews
India’s risks overdose on medical inflation fix
A parliamentary panel recommends curbing foreign funding in healthcare just as KKR buys Medicover’s India hospitals for $1.4 bln. But price rises reflect a maturing industry. Restricting capital would...
KKR To Acquire Medicover India, Expanding Healthcare Investment In South Asia; Stock Up
(RTTNews) - KKR, an investment firm, announced that it has signed definitive agreements to acquire Medicover India, the hospital operations of Medicover AB (MCOV_B.ST).
Medicover AB Transcript: Investor update
A full divestment of the Indian hospital business to KKR for EUR 1.2 billion enterprise value will strengthen the balance sheet, improve margins, and allow greater strategic focus on core European markets. Revenue mix and growth guidance remain largely unchanged, with further details to follow post-closing.
Medicover AB Press release: Investor update
Medicover AB issued a press release on August 6, 2026, disclosing material business information to investors.
Medicover AB Slides: Investor update
Medicover AB has posted slides in relation to its latest quarterly earnings report, which was published on August 6, 2026.
KKR To Acquire Medicover India's Hospital Operations From Medicover AB
(RTTNews) - KKR & Co. Inc. (KKR) on Thursday agreed to acquire Medicover India, the Indian hospital operations of Medicover AB (MCOV B.ST, MCVEF), for an undisclosed amount.
Medicover AB Earnings Call Transcript: Q2 2026
Double-digit organic revenue growth and margin expansion continued, with strong results in Diagnostics and India, improved cash flow, and leverage below 3x. Strategic options for the Indian business are under review, and midterm financial targets remain on track.
Medicover AB Quarterly report: Q2 2026
Medicover AB has published its Q2 2026 quarterly earnings report on July 22, 2026.
Medicover AB Slides: Q2 2026
Medicover AB has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 22, 2026.
Medicover AB Earnings Call Transcript: Q1 2026
Q1 2026 delivered strong organic growth of 10.3% and margin expansion, with revenue at €624.2 million and adjusted EBITDA up 15.4%. India and Diagnostic Services led growth, while weather and geopolitical headwinds were effectively managed.
Medicover AB Quarterly report: Q1 2026
Medicover AB has published its Q1 2026 quarterly earnings report on April 29, 2026.
Medicover AB Slides: Q1 2026
Medicover AB has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on April 29, 2026.
Medicover AB Transcript: Investor Update
Strong organic growth, margin expansion, and disciplined investment have positioned the group for ambitious 2028 targets, with double-digit revenue and EBITDA growth expected. Key markets—Poland, Germany, Romania, and India—drive performance, supported by digital innovation and operational leverage.
Medicover AB Press release: Investor Update
Medicover AB issued a press release on February 11, 2026, disclosing material business information to investors.
Medicover AB Slides: Investor Update
Medicover AB has posted slides in relation to its latest quarterly earnings report, which was published on February 11, 2026.
Medicover AB Earnings Call Transcript: Q4 2025
Double-digit revenue and profit growth in Q4 and FY 2025, with margin expansion and strong cash flow, driven by robust demand in core markets and successful integration of acquisitions. Achieved all three-year financial targets and set ambitious new goals for 2028.
Medicover AB Annual report: Q4 2025
Medicover AB has published its Q4 2025 annual report on February 10, 2026.
Medicover AB Quarterly report: Q4 2025
Medicover AB has published its Q4 2025 quarterly earnings report on February 10, 2026.
Medicover AB Slides: Q4 2025
Medicover AB has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 10, 2026.
Medicover AB Earnings Call Transcript: Q3 2025
Q3 saw strong organic growth, margin expansion, and robust cash flow, with both healthcare and diagnostics segments performing well. Guidance for the full year is unchanged, with expectations to beat revenue and EBITDA targets, despite some consumer caution and operational headwinds.
Medicover AB Quarterly report: Q3 2025
Medicover AB has published its Q3 2025 quarterly earnings report on November 5, 2025.
Medicover AB Slides: Q3 2025
Medicover AB has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 5, 2025.